OTC MAP is Back
January 20, 2005 Volume 7 / Number 3 Dear Colleague: Greed-driven manufacturers of the morning-after pill (MAP) are hoping that the FDA will soon approve this abortifacient drug for over-the-counter sale. Eight months ago the FDA rightly rejected this very bad idea. Nothing has changed